期刊文献+

1例伏立康唑-地西泮相互作用致过度镇静的病例分析 被引量:4

下载PDF
导出
摘要 目的:通过对临床药师参与的1例ICU真菌、细菌合并感染患者抗感染治疗过程中出现过度镇静、神智不清的原因进行分析,探讨在临床治疗过程中临床药师对于药物相互作用导致不良反应时所发挥的作用.方法:针对患者病情及用药情况,从患者自身因素和药物因素探讨服用地西泮后处于浅昏迷状态及苏醒延迟的原因,为ICU常规镇痛镇静患者提供合理的处理建议.结果:医师采纳临床药师建议,停用地西泮片,并给予氟马西尼促醒、血浆置换等治疗后患者神智好转,顺利拔除气管插管.结论:重症患者使用药物品种较多,在治疗过程中易引起相互作用,影响治疗效果.临床药师需结合患者的具体情况,注意判断患者的异常临床表现是否与用药相关,从而使临床药师的参与能够协助医师提高临床治疗水平,促进合理用药.
出处 《转化医学电子杂志》 2016年第2期58-59,共2页 E-Journal of Translational Medicine
  • 相关文献

参考文献6

二级参考文献60

  • 1[1]Riva R,Albani M,Baruzzi A.Pharmacokinetic interactions between antiepileptic drugs.Clinical considerations[J].Clin Pharmacokinet,1996,31(6):470-493.
  • 2[4]Brouwers JR,de Smet PA.Pharmacokinetic-pharmacodynamic drug interactions with nonsteroidal anti-inflammatory drugs[J].Clin Pharmacokinet,1994,27(6):462-485.
  • 3[8]Moriya F,Ishizu H.Interactive effects of ethanol on benzodiazepines levels in blood and brain of rat[J].Arukoru Kenkyuto Yakubutsu Ison,1992,27(3):254-265.
  • 4[9]Gardner MJ,Baris BA,Wilner KD,et al.Effect of serraline on the pharmacokinetics and protein binding of diazepam in healthy volunteers[J].Clin Pharmacokinet,1997,32(1):43-49.
  • 5[11]Greenblatt DJ,Abernethy DR,Koepke HH,et al.Interaction of cimetidine with oxazepam,lorazepam,and flurazepam[J].I Clin Pharmacol,1984,24(4):187-193.
  • 6[12]Kanda H,Yasui-Furakori N,Fukasawa T,et al.Interaction study between fluvoxamine and quazepam[J].J Clin Pharmacol,2003,43(12):1392-1397.
  • 7[13]Yasut-Furukori N,Kondo T,Takahara K,et al.Effect of dietary fat content in meals on pharmacokinetics of quazepam[J].J Clin pharmacol,2002,42(12):1335-1340.
  • 8[14]Dolin SJ,Patch TL,Rabbani M,et al.Different interactions between benzodiazepines and the dihydropyridines,nitrendipine and Bay K 8644[J].Neuropharmacology,1991,30(3):217-224.
  • 9[15]McAdam LC,Macdonald JF,Orser BA.Isobolographic analysis of the interactions between midazolam and propofol at GABA(A)receptors in embryonic mouse neurons[J].Anesthesiology,1998,89(6):1444-1454.
  • 10[16]Dresser GK,Spence JD,Bailey DG.Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition[J].Clin Pharmacokinet,2000,38(1):41-57.

共引文献37

同被引文献23

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部